Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.36)
# 1,043
Out of 5,105 analysts
270
Total ratings
51.83%
Success rate
1.79%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $410 → $405 | $354.09 | +14.38% | 13 | Oct 31, 2025 | |
| ILMN Illumina | Maintains: Outperform | $132 → $142 | $134.87 | +5.29% | 9 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $88 → $92 | $83.08 | +10.74% | 15 | Oct 31, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $88 → $92 | $83.96 | +9.58% | 5 | Oct 30, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $17 → $18 | $16.99 | +5.94% | 11 | Oct 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $16 → $14 | $11.17 | +25.34% | 12 | Oct 30, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $155 → $168 | $198.68 | -15.44% | 8 | Oct 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $142 | $125.46 | +13.18% | 17 | Oct 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $106 → $104 | $91.59 | +13.55% | 14 | Oct 7, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $46 → $42 | $30.93 | +35.79% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $572.28 | +3.10% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $100.49 | +5.48% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $312.02 | -8.66% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,393.64 | +0.46% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $535 → $450 | $542.32 | -17.02% | 14 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $175 | $168.84 | +3.65% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $68 | $101.50 | -33.00% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $226.33 | +8.25% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $92.58 | +18.82% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $19.15 | +61.88% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $128 → $140 | $139.68 | +0.23% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $69 → $78 | $75.00 | +4.00% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $53.42 | +1.09% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $26.76 | +49.48% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $35 → $33 | $35.30 | -6.52% | 8 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $99.87 | +6.14% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $26.47 | +73.78% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.49 | +20.48% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $13.33 | +125.14% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $385.33 | -7.87% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $77.77 | +105.73% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $200.89 | +44.36% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.00 | +602.88% | 1 | May 31, 2022 |
Stryker
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $354.09
Upside: +14.38%
Illumina
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $134.87
Upside: +5.29%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $83.08
Upside: +10.74%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $83.96
Upside: +9.58%
Bausch + Lomb
Oct 30, 2025
Maintains: Outperform
Price Target: $17 → $18
Current: $16.99
Upside: +5.94%
Avantor
Oct 30, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $11.17
Upside: +25.34%
J.B. Hunt Transport Services
Oct 16, 2025
Maintains: Outperform
Price Target: $155 → $168
Current: $198.68
Upside: -15.44%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $144 → $142
Current: $125.46
Upside: +13.18%
Zimmer Biomet Holdings
Oct 7, 2025
Maintains: In-Line
Price Target: $106 → $104
Current: $91.59
Upside: +13.55%
Twist Bioscience
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $30.93
Upside: +35.79%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $572.28
Upside: +3.10%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $100.49
Upside: +5.48%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $312.02
Upside: -8.66%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,393.64
Upside: +0.46%
Oct 7, 2025
Maintains: In-Line
Price Target: $535 → $450
Current: $542.32
Upside: -17.02%
Oct 7, 2025
Maintains: In-Line
Price Target: $185 → $175
Current: $168.84
Upside: +3.65%
Oct 7, 2025
Maintains: Outperform
Price Target: $64 → $68
Current: $101.50
Upside: -33.00%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $226.33
Upside: +8.25%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $92.58
Upside: +18.82%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $19.15
Upside: +61.88%
Oct 7, 2025
Maintains: In-Line
Price Target: $128 → $140
Current: $139.68
Upside: +0.23%
Oct 7, 2025
Upgrades: Outperform
Price Target: $69 → $78
Current: $75.00
Upside: +4.00%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $53.42
Upside: +1.09%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $26.76
Upside: +49.48%
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $35.30
Upside: -6.52%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $99.87
Upside: +6.14%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $26.47
Upside: +73.78%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.49
Upside: +20.48%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $13.33
Upside: +125.14%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $385.33
Upside: -7.87%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $77.77
Upside: +105.73%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $200.89
Upside: +44.36%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.00
Upside: +602.88%